SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings (ONDS) is gaining traction following multiple analyst upgrades and an increased revenue outlook, with community discussions centered on its potential in drone and autonomous systems for critical infrastructure and defense. Investors are actively debating the stock's volatility, weighing recent upgrades and anticipated large contracts against observed market dynamics and short-term trading patterns.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing an explosive rally, fueled by reports of significant and immediate price increases across the memory semiconductor market, driven by robust AI data center demand and tightening supply. This has ignited a fierce debate within the community, with many celebrating 'generational' gains and anticipating further parabolic moves, while skeptics warn of unsustainable valuation and potential manipulation akin to past market bubbles. The stock's performance is further bolstered by a major analyst upgrade citing favorable supply-demand dynamics and its position in the evolving AI infrastructure landscape.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing a significant surge after President Trump announced a "framework deal" with NATO regarding Greenland and paused planned European tariffs, prompting a relief rally. The community is sharply divided, with bulls celebrating immediate gains from this "TACO Trade," while skeptics widely debate if the bounce is a genuine market shift or a politically orchestrated "fake pump" ahead of broader underlying market concerns.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending amidst strong community discussion surrounding its strategic push into artificial intelligence, particularly the anticipated spin-off and listing of its T-Head AI chip unit and the growing integration of its Qwen AI models across its ecosystem. This focus is fueling bullish sentiment and talk of a re-rating for Chinese tech, even as some market participants express caution regarding broader macroeconomic factors and geopolitical dynamics.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

Invesco QQQ Trust is experiencing a notable surge after President Trump announced a "framework deal" with NATO on Greenland, leading to the cancellation of planned tariffs on Europe. This "TACO" trade has sparked widespread community discussion, with bulls celebrating the predictable bounce while others express frustration over the market's politically-driven swings. The abrupt reversal of tariff threats has significantly eased geopolitical concerns, benefiting the tech-heavy index.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is actively trending as recent token burns aim to boost scarcity, alongside its evolving role as a 'universal gas token' and the introduction of new Web3 games and 'Learn & Earn' features. The community remains divided, with some highlighting its long-term move-to-earn potential and ecosystem growth, while others caution about its volatility.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is actively trending following the FDA approval of Orladeyo for pediatric Hereditary Angioedema (HAE), alongside the recent shareholder approval of its merger with Astria Therapeutics. Despite this positive regulatory news, the community expresses frustration over persistent stock underperformance, with many discussing potential dilution from the merger and perceived market manipulation. Investors are now keenly awaiting further guidance from new leadership, hoping these strategic moves will eventually unlock significant value in the HAE market.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a significant pre-earnings rally, driven by growing optimism for its advanced AI hardware and strategic importance as a domestic chip manufacturer. The community is vigorously debating a potential short squeeze, with many anticipating substantial upside on upcoming foundry and product announcements, while some caution about a post-earnings pullback.

Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. The firm offers vehicle sellers a full range of services to process and sell vehicles primarily over the internet through Virtual Bidding Third Generation Internet auction-style sales technology. It sells vehicles principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, exporters and at certain locations, and the public. The company’s services include online seller access, salvage estimation services, estimating services, end-of-life vehicle processing, virtual insured exchange, transportation services, vehicle inspection stations, on-demand reporting, DMV processing, and vehicle processing programs. It operates through the United States and International segments. The company was founded by Willis J. Johnson in 1982 and is headquartered in Dallas, TX.

Copart, Inc.

Copart is trending amid anticipation of its next fiscal quarter earnings, sparking a lively debate among investors regarding its future trajectory. Many community members highlight bullish technical signals and potential for a rebound from recent underperformance, driven by its dominant position in online vehicle auctions and strategic AI integrations. However, some remain cautious, pointing to a recent cool-down in growth momentum and increased competition within the sector.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed Inc. is trending after its subsidiary, Lucid Diagnostics, secured a significant U.S. Department of Veterans Affairs contract for its EsoGuard Esophageal DNA Test, expanding access across a large healthcare system. The community is buzzing about the stock's low float and high short interest, with many anticipating a substantial short squeeze and extreme volatility. Discussions are active regarding potential continued upward momentum versus concerns about profit-taking and possible dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QRG Capital Management Inc. Sells 28,885 Shares of Exelixis, Inc. $EXEL

QRG Capital Management Inc. cut its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 53.8% during the third quarter, according to the company in its most recent Form 13F filing with...

Seizert Capital Partners LLC Trims Holdings in Exelixis, Inc. $EXEL

Seizert Capital Partners LLC decreased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 15.9% in the third quarter, according to its most recent 13F filing with the Securities and...

SG Americas Securities LLC Lowers Holdings in Exelixis, Inc. $EXEL

SG Americas Securities LLC lowered its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 69.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange...

Exelixis, Inc. $EXEL Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC cut its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 83.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

Exelixis, Inc. $EXEL Shares Sold by EULAV Asset Management

EULAV Asset Management trimmed its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 4.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 570,050...

Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Meritage Portfolio Management Has $12.20 Million Stock Position in Exelixis, Inc. $EXEL

Meritage Portfolio Management lessened its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 21.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The...

Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Recommendation of "Hold" from Analysts

Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) has been assigned an average recommendation of "Hold" from the twenty-six research firms that are presently covering the stock, Marketbeat Ratings...

Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?

Exelixis (EXEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Exelixis (NASDAQ:EXEL) Shares Gap Down - Should You Sell?

Exelixis (NASDAQ:EXEL) Shares Gap Down - Here's What Happened...

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Exelixis Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.82	--	--	N/A
Q3 '25	$0.69	$0.78	13.87%	BEAT
Q2 '25	$0.66	$0.75	14.41%	BEAT
Q1 '25	$0.36	$0.62	70.90%	BEAT
Q4 '24	$0.43	$0.48	12.81%	BEAT

EXEL
Exelixis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest EXEL News

EXELExelixis Inc